| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | SR-3029 is a strong inhibitor of CK1δ/CK1ε, with IC50 values of 44 nM and 260 nM, respectively. It competes with ATP, having Kis of 97 nM for CK1δ/CK1ε. SR-3029 also inhibits CDK6/cyclin D3, CDK6/cyclin D1, CDK4/cyclin D3, CDK4/cyclin D1, and FLT3, with IC50s of 427, 428, 368, 576, and 3000 nM, respectively. It exhibits inhibitory activity on A375 cells, with an EC50 of 86 nM[1]. SR-3029's efficacy is lower against MCF7 and T47D breast cancer cells, as well as the MCF10A cell line, all of which have low CK1δ expression[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.08mL 0.42mL 0.21mL | 10.41mL 2.08mL 1.04mL | 20.81mL 4.16mL 2.08mL | 
| 参考文献 | 
|---|